News

Plans about the project was announced by the company in 2010 and also received $8.4m in loans from the local government and other assistance from the city. City

The collaboration will integrate Genmab’s high-affinity fully human antibody targeting CD25, HuMax-TAC, with ADC’s PBD-based warhead and linker technology for the devlopment of new product. Genmab chief executive

The first new medicine that is globally approved for newly diagnosed glioblastoma is cleared for use in combination with radiotherapy and temozolomide chemotherapy, and as monotherapy. Avastin is

The company will unveil the platform at the 49th Drug Information Association (DIA) annual meeting scheduled to be held between 23 June 2013 and 27 June 2013 in

Japan-based Innovation Network Corporation led the funding. PRI-724, which is currently in clinical trials for the treatment of solid tumors and leukemia, is an antiproliferative small molecule that

An orally available Janus kinase (JAK) inhibitor, Baricitinib is being studied to treat certain autoimmune conditions, including RA. Clinical improvements which were observed at 24-week continued at the

The study is intended to assess safety, tolerability and efficacy in patients suffering from one of the most serious manifestations of systemic lupus erythematosus (SLE or lupus) that

The drugs are intended to clear the accumulated beta-amyloid from the brain resulting in a halt or reverse the series of Alzheimer’s disease. The company has recognized a

Kitasato Daiichi Sankyo Vaccine and JICA have provided technical assistance to Vietnam’s Center for Research and Production of Vaccines and Biologicals (POLYVAC) to produce the measles vaccine from